cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer. Academic Article uri icon

Overview

abstract

  • Treatment with a combination of adriamycin (ADM) and cis-dichlorodiammineplatinum(II) (DDP) has been evaluated in 24 patients with advanced ovarian cancer. Twenty patients had received prior chemotherapy and/or radiation therapy. Objective remissions were seen in ten patients. The usual toxic manifestations of ADM and DDP were observed. It is concluded that the combination is effective therapy for ovarian cancer. Further investigation of this combination versus single agents is warranted.

publication date

  • December 1, 1978

Research

keywords

  • Cisplatin
  • Doxorubicin
  • Ovarian Neoplasms

Identity

Scopus Document Identifier

  • 0018200662

PubMed ID

  • 751711

Additional Document Info

volume

  • 62

issue

  • 12